THE SPECIFICITY OF P53 MUTATION SPECTRA IN SUNLIGHT-INDUCED HUMAN CANCERS

被引:137
|
作者
DAYAGROSJEAN, L
DUMAZ, N
SARASIN, A
机构
[1] Laboratory of Molecular Genetics, Institut de Recherche sur le Cancer (IFC 1), 94801 Villejuif Cedex
关键词
UV; MUTAGENESIS; P53; CANCERS;
D O I
10.1016/1011-1344(95)07130-T
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ultraviolet (UV) irradiation emitted by the sun has been dearly implicated as a major carcinogen in the formation of skin cancers in man. Indeed, the high levels of cutaneous tumors in xeroderma pigmentosum patients (XP) who are deficient in repair of UV-induced lesions have confirmed that DNA damage produced by sunlight is directly involved in the cancer development. The tumor suppressor gene, p53, very frequently found modified in human cancers, has proved to be a perfect target gene for correlating mutation spectra with different cancer causing agents as there are nearly 300 potential mutation sites available for analysis. In a comparative analysis of p53 mutations found in internal cancers with those in skin tumours we show here that clear differences exist between the types of spectra obtained. The specificity of UV induced mutations in skin cancers is confirmed when single and tandem mutations are compared. Most of the p53 point mutations found are GC to AT transitions both in skin and internal tumors where in the latter they are located mainly at CpG sequences probably due to the deamination of the unstable 5-MeC. Moreover, mutations are targeted at py-py sequences in over 90% of skin tumors whereas in internal cancers the distribution is proportional to the frequency of bipyrimidine sequences in the p53 gene. Most significantly, all mutations found in XP skin tumors are targeted at py-py sites and more than 50% are tandem CC to TT transitions considered as veritable signatures of UV-induced lesions. Tandem mutations are also relatively common (14%) in skin tumors from normal individuals compared to their very rare occurrence in internal malignancies (0.8%). Finally, nearly all mutations observed in XP skin tumors are due to unrepaired lesions remaining on the coding strand whereas no strand bias is seen in mutation location of internal or skin tumors from normal individuals. In fact the mutation spectrum analysed in XP skin cancers has permitted the first demonstration of the existence of preferential repair in man. In conclusion, using the p53 gene as a probe it is obvious that the mutation spectra from skin tumors are very similar to those observed in UV-treated gene targets in model systems but statistically different from those described in other types of human cancer. This has allowed us to demonstrate, without ambiguity, the major role of UV-induced DNA lesions in sunlight related skin carcinogenesis.
引用
收藏
页码:115 / 124
页数:10
相关论文
共 50 条
  • [31] Heterogeneity of p53 mutation in human breast cancer
    Tawfik, H
    El-Monem, HA
    Craft, JA
    Going, JJ
    JOURNAL OF PATHOLOGY, 2001, 193 : 5A - 5A
  • [32] P53 GENE MUTATION IN HUMAN SOLID TUMORS
    THEILLET, C
    BULLETIN DU CANCER, 1993, 80 (08) : 693 - 696
  • [33] p73 and p53 pathway in human breast cancers
    Bozzetti, Cecilia
    Nizzoli, Rita
    Musolino, Antonino
    Martella, Eugenia M.
    Crafa, Pellegrino
    Lagrasta, Costanza A.
    Camisa, Roberta
    Bonati, Antonio
    Lunghi, Paolo
    Ardizzoni, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (11) : 1451 - 1453
  • [34] p53 status in multiple human urothelial cancers:: Assessment for clonality by the yeast p53 functional assay in combination with p53 immunohistochemistry
    Yamamoto, S
    Tada, M
    Lee, CCR
    Masuda, C
    Wanibuchi, H
    Yoshimura, R
    Wada, S
    Yamamoto, K
    Kishimoto, T
    Fukushima, S
    JAPANESE JOURNAL OF CANCER RESEARCH, 2000, 91 (02): : 181 - 189
  • [35] p53 protein accumulation in non-invasive lesions surrounding p53 mutation positive invasive breast cancers
    Done, SJ
    Arneson, NCR
    Özçelik, H
    Redston, M
    Andrulis, IL
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 65 (02) : 111 - 118
  • [36] New approaches to understanding p53 gene tumor mutation spectra
    Hollstein, M
    Hergenhahn, M
    Yang, Q
    Bartsch, H
    Wang, ZQ
    Hainaut, P
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1999, 431 (02) : 199 - 209
  • [37] p53 Protein Accumulation in Non-Invasive Lesions Surrounding p53 Mutation Positive Invasive Breast Cancers
    Susan J. Done
    Nona C.R. Arneson
    Hilmi Özçelik
    Mark Redston
    Irene L. Andrulis
    Breast Cancer Research and Treatment, 2001, 65 : 111 - 118
  • [38] Image analysis for the evaluation of p53 expression in human cancers
    Faranda, A
    Silvestrini, R
    Canova, S
    Costa, A
    ANALYTICAL CELLULAR PATHOLOGY, 1996, 11 (02): : 107 - 113
  • [39] Tumor suppressor gene p53 in human oral cancers
    Tandle, A
    Teni, T
    Saranath, D
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 171 - 174
  • [40] MUTATIONS IN THE P53 GENE IN PRIMARY HUMAN BREAST CANCERS
    OSBORNE, RJ
    MERLO, GR
    MITSUDOMI, T
    VENESIO, T
    LISCIA, DS
    CAPPA, APM
    CHIBA, I
    TAKAHASHI, T
    NAU, MM
    CALLAHAN, R
    MINNA, JD
    CANCER RESEARCH, 1991, 51 (22) : 6194 - 6198